This Week in Psychedelics

The surprising ways psilocybin use impacts how we work; Massachusetts activists seek to get a pair of initiatives on the 2024 ballot.

August 4, 2023

This Week...

Massachusetts activists filed a pair of initiatives to legalize the possession of certain psychedelics and allow for licensed facilities to provide supervised services. The initiatives could go before voters on the state’s 2024 ballot. Check it out:

A new study explores how employees’ lifetime psilocybin use relates to the amount of overtime they worked, thereby offering insight into what current trends in psilocybin use could mean for businesses.

The findings of the study suggest that lifetime psilocybin use in the U.S. full-time working population is associated with an estimated 44,348,400 fewer overtime hours worked per year and may help explain recent findings linking employees’ lifetime psilocybin use to a reduction in sick leave taken. Here’s more:

Top federal health officials pronounced that psychedelics have “promising” therapeutic potential, but research into them has been stymied by ongoing federal prohibition. They also argue that as the Food and Drug Administration considers approving substances like psilocybin, it’s important to look at issues such as accessibility, affordability, health care reimbursements and ethics. Check it out:

Did You Know?

Did you know that the first western experiments with ibogaine took place in 1935 in an addiction treatment center called the Narcotics Farm?

The coed facility not only housed convicted drug offenders, but also those who voluntarily checked in for drug rehabilitation. It housed everyone from famous jazz musicians, to addicted doctors, to drugstore cowboys, to William S. Burroughs, who notably wrote about his time at Narco in his book, Junkie. Check it out: